Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence

BACKGROUND: The ERBB2 oncogene hypothesis is challenged in hepatocellular carcinoma (HCC) with the conflicting evidences of human epidermal growth factor receptor 2 (HER2) overexpression. HER2 could be a new target as a treatment option for HCC as well as tumor recurrence after surgery. HER2 in HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ji‐Hua, Guo, Wen‐Zhi, Jin, Yang, Zhang, Hua-Peng, Pang, Chun, Li, Jie, Line, Pål‐Dag, Zhang, Shui‐Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434216/
https://www.ncbi.nlm.nih.gov/pubmed/30714677
http://dx.doi.org/10.1002/cam4.2006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434216/
https://www.ncbi.nlm.nih.gov/pubmed/30714677
http://dx.doi.org/10.1002/cam4.2006

Ejemplares similares